Ticker: RXRX

Company: RECURSION PHARMACEUTICALS, INC.

Person: Blake Borgeson, director

Transaction date: Aug. 4, 2026

Reporting date: Aug. 6, 2026

Average share price: 3.25

Sold 30000.0 shares for 97500.0